Attached files
| file | filename |
|---|---|
| EX-32.2 - AERI 12.31.2019 EX 32.2 - AERIE PHARMACEUTICALS INC | aeri12312019ex-322.htm |
| EX-32.1 - AERI 12.31.2019 EX 32.1 - AERIE PHARMACEUTICALS INC | aeri12312019ex-321.htm |
| EX-31.2 - AERI 12.31.2019 EX 31.2 - AERIE PHARMACEUTICALS INC | aeri12312019ex-312.htm |
| EX-31.1 - AERI 12.31.2019 EX 31.1 - AERIE PHARMACEUTICALS INC | aeri12312019ex-311.htm |
| EX-10.31 - EXHIBIT 10.31 - AERIE PHARMACEUTICALS INC | firstamendmenttoaeriep.htm |
| EX-10.30 - EXHIBIT 10.30 - AERIE PHARMACEUTICALS INC | aeri-formofrsuagreement.htm |
| EX-10.23 - EXHIBIT 10.23 - AERIE PHARMACEUTICALS INC | aerieemploymentagreeme.htm |
| EX-4.3 - EXHIBIT 4.3 - AERIE PHARMACEUTICALS INC | aerie10-kxdescriptiono.htm |
| 10-K - 10-K - AERIE PHARMACEUTICALS INC | aeri-1231201910xk.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (Nos. 333-228247, 333-223364, 333-221442, 333-219671, 333-216578, 333-216577 and 333-192030) of Aerie Pharmaceuticals, Inc. of our report dated February 24, 2020 relating to the financial statements and the effectiveness of internal control over financial reporting, which appears in this Form 10-K.
/s/ PricewaterhouseCoopers LLP
Florham Park, New Jersey
February 24, 2020